Davis Capital Management
PFE icon

Davis Capital Management’s Pfizer PFE Stock Holding History

Davis Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.99K Buy
140
+3
+2% +$80 ﹤0.01% 331
2026
Q2 		$3.3K Buy
137
+87
+174% +$2.28K ﹤0.01% 347
2026
Q1 		$1.4K Hold
50
– – ﹤0.01% 313
2025
Q4 		$1.24K Sell
50
-11
-18% -$277 ﹤0.01% 318
2025
Q3 		$1.55K Buy
+61
New +$1.51K ﹤0.01% 313
2024
Q1 		– Sell
-140
Closed -$4.03K – 298
2023
Q4 		$4.03K Buy
+140
New +$4.23K ﹤0.01% 255
2020
Q2 		$668K Buy
21,527
+2,608
+14% +$88.6K 1.23% 33
2020
Q1 		$586K Buy
+18,919
New +$645K 1.24% 29

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Davis Capital Management's PFE Position: Q3 2026 in Review

Davis Capital Management increased its Pfizer (PFE) stake by 2.2% in Q3 2026, buying an estimated $80 and bringing the position to 140 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #331.

Davis Capital Management first reported a position in PFE in Q1 2020 and has held it in 8 quarters since. The position peaked at $668K in Q2 2020. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Davis Capital Management held 140 shares of Pfizer worth $3.99K as of Q3 2026.
  • Davis Capital Management bought 3 Pfizer shares in Q3 2026, an estimated $80.
  • Pfizer made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #331 holding.
  • Davis Capital Management first reported a position in Pfizer in Q1 2020 and has held it in 8 quarters since.
  • Davis Capital Management's Pfizer position peaked at $668K in Q2 2020.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.